Recipharm has secured a five-year $114.9 million loan for future expansion plans in the field of contract pharmaceutical development. The company plans to increase capital investment in existing sites and facilities, as well as support a program of strategic acquisitions. Resources will also be assigned to building and enhancing existing and new customer relationships.   Thomas Eldered, chief executive officer of Recipham AB, said, “The new financing will serve to bolster initiatives designed to...